Andrew Hack

Andrew Hack

Director/Board Member at NUVALENT, INC.

Net worth: 197 773 $ as of 2024-03-30

50 year
Health Technology
Finance
Consumer Services

Profile

Andrew A.
F.
Hack
founded Reify Corp.
in 2002, where he worked as Director-Life Sciences from 2002 to 2004.
Dr. Hack also currently works at Mersana Therapeutics, Inc., as Independent Director from 2017, JenaValve Technology, Inc., as Director, Affinivax, Inc., as Director, Imperative Care, Inc., as Director, Nuvalent, Inc., as Independent Director from 2021, and Bain Capital Life Sciences LP, as Partner from 2019.
Dr. Hack also formerly worked at Life Sciences, Inc., as Director from 2002 to 2004, Dynavax Technologies Corp., as Independent Director from 2021 to 2023, Atea Pharmaceuticals, Inc., as Independent Director from 2020 to 2021, Allena Pharmaceuticals, Inc., as Independent Director from 2018 to 2021, Xilio Therapeutics, Inc., as Director in 2021, BCLS Acquisition Corp., as Chief Financial Officer & Director, MPM BioEquities Adviser LLC, as Analyst from 2006 to 2007, HealthCor Management LP, as Analyst from 2009 to 2011, MPM BioImpact, Inc, as Principal from 2006 to 2007, Millennium Management LLC, as Portfolio Manager from 2011 to 2015, Carlyle-Blue Wave Partners, as Analyst from 2007 to 2008, and Editas Medicine, Inc., as Chief Financial & Accounting Officer from 2015 to 2019.
Dr. Hack received his undergraduate degree, graduate degree, and doctorate degree from The University of Chicago.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-06-13 10,714 ( 0.01% ) 132 961 $ 2024-03-30
2023-06-07 14,467 ( 0.01% ) 64 812 $ 2024-03-30
2023-06-14 0 ( -.--% ) - $ 2024-03-30

Andrew Hack active positions

CompaniesPositionStart
MERSANA THERAPEUTICS, INC. Director/Board Member 2017-01-05
NUVALENT, INC. Director/Board Member 2021-05-10
Director/Board Member -
Director/Board Member -
Director/Board Member -
Private Equity Investor 2019-02-28
All active positions of Andrew Hack

Former positions of Andrew Hack

CompaniesPositionEnd
DYNAVAX TECHNOLOGIES CORPORATION Chairman 2021-10-18
XILIO THERAPEUTICS, INC. Director/Board Member 2021-09-30
ATEA PHARMACEUTICALS, INC. Director/Board Member 2021-06-17
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░ ░░ ░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Andrew Hack's experience

Training of Andrew Hack

The University of Chicago Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Hack's experience

Connections

94

1st degree connections

20

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies6
DYNAVAX TECHNOLOGIES CORPORATION

Health Technology

MERSANA THERAPEUTICS, INC.

Health Technology

ATEA PHARMACEUTICALS, INC.

Health Technology

EDITAS MEDICINE, INC.

Health Technology

XILIO THERAPEUTICS, INC.

Health Technology

ALLENA PHARMACEUTICALS, INC.

Health Technology

Private companies13

Health Technology

Finance

Finance

Finance

Finance

Finance

Health Technology

Health Technology

Finance

Technology Services

Health Technology

Nuvalent, Inc.

Finance

See company connections